Mycoses
53
1
1
45
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
13 trials with published results (25%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
1.9%
1 terminated out of 53 trials
97.8%
+11.3% vs benchmark
40%
21 trials in Phase 3/4
29%
13 of 45 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 45 completed trials
Clinical Trials (53)
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
Prospective Data Bank Creation to Study Vaginal Conditions
Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects
Liver Transplant European Study Into the Prevention of Fungal Infection
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites
A Study of Itraconazole in the Management of Superficial Fungal Infections in India
Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
Effect of Inflammation on Pharmacokinetics of Posaconazole
Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations
Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization